Furthermore, HCC patients at stage III exhibited higher CCAT2 expression levels in tumour than those at stages I/II (0.00045 ± 0.00008 vs. 0.00022 ± 0.00005, p < 0.05, Figure 1B). The gene discussed is CCAT2; the disease is hepatocellular carcinoma.